Lab Notes: Code Bio makes potential $2B deal; Marinus suffers Covid-related setback
February 25, 2022 at 13:35 PM EST
The Center for Breakthrough Medicines has formed a cell and gene therapy partnership with a Philadelphia CRO.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |